UpdatesPress Release
Sun Pharma committed to Most Favored Nation (MFN) pricing for US Medicaid and future innovative medicines.
Sun Pharmaceutical Industries LimitedSUNPHARMA · Filed with the exchange
In return, it secured a two-year delay on Section 232 tariffs for innovative pharmaceutical products, aiding US patients and benefiting the company.
No comments yet. Be the first.